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Abstract
• Isolated liver metastases from  breast cancer is rare and only seen in 5-12% of 
breast cancer patients1.
• We report a rare case of metastatic triple-negative invasive ductal carcinoma 
presenting as isolated post-surgical acute liver failure in a patient previously in 
remission. 
• Prior studies have demonstrated good prognosis in patients with isolated liver 
involvement if they have had prolonged disease-free interval, hormone positive 
cancer, and normal liver function2. 
• Our patient presents a challenging case in which liver function and performance 
status were poor prior to diagnosis of metastasis. Helical CT also demonstrated a 
unique presentation of cirrhotic liver with vastly diffuse metastatic lesions, with 
no circumscribed mass seen.
• The findings of this case emphasize the unique presentations of metastatic breast 
cancer in patients who are in remission, necessitating a broader differential 
diagnosis at time of presentation.
Case Description
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Clinical Images
Conclusions
• A 45 year-old-female with history of stage IA ER,PR,Her2 negative moderately 
differentiated ductal carcinoma of the right breast (s/p neoadjuvant chemotherapy, 
lumpectomy, and adjuvant therapy) presented with abdominal pain, abdominal 
distension, jaundice, and scleral icterus three weeks after laparoscopic 
cholecystectomy.
• Intraoperatively, her liver appeared cirrhotic which prompted an intraoperative 
biopsy. This demonstrated fragments of benign liver cyst with granulomatous 
inflammation, attributed to a subcapsular sample. 
• During a postoperative office visit, total bilirubin was elevated (2.6 on 
admission, 10.6 on discharge).
• On presentation she showed signs of acute liver failure and coagulopathy with a 
bilirubin of 11.2, INR 3.45, and AST/ALT 182 and 115 respectively. Clinically 
she continued to have increased abdominal pain and distension, jaundice, and 
scleral icterus. 
• Causes of acute liver failure including post-surgical complications, viral, 
autoimmune, and granulomatous disease were excluded.
• During her hospital course she continued to display worsening liver function 
with elevated AST/ALT, total bilirubin, alkaline phosphatase, and INR. Further 
evaluation with transjugular hepatic biopsy was done due to limited diagnostic 
value of biopsy from outside hospital. Immunohistochemical staining was positive 
for GATA-3 immunostain and CK-7 stain, revealing adenocarcinoma consistent 
with primary breast carcinoma. 
• Our patient presents a challenging case in which metastatic breast cancer presented with 
acute liver failure.
• Helical CT demonstrated severe cirrhosis with no distinct lesions concerning for 
metastasis, which led to a delay in diagnosis.
• Suspicion for malignant causes should remain high even in breast cancer patients who 
have completed treatment and have negative image-based screening for metastasis.
• The findings of this case support the importance of liver biopsy as a definitive 
diagnostic tool, as late discovery of metastasis results in a poor prognosis.
Day 0
• Acute Liver Failure (ALF) is defined as sudden liver dysfunction manifesting as 
coagulopathy and any degree of encephalopathy in a patient without preexisting 
cirrhosis with illness lasting less than 26 weeks' duration1. 
• As much as 20-40% of ALF is due to unclear causes4. 
• In the case of breast cancer metastases, the liver is considered to among the 
common sites of metastasis, along with lungs and bone3. However, most metastases 
present in the form of a discrete mass3.
• In a large retrospective study, Rowbotham and associates analyzed 4,020 ALF cases 
over an 18-year period and attributed only 0.44% of these cases to malignant 
hepatic infiltration5.
• Our patient’s breast cancer was grade 2 triple negative infiltrating ductal carcinoma, 
which was adequately treated with neoadjuvant chemotherapy, right partial 
mastectomy, right axillary sentinel node biopsy, and postoperative adjuvant 
radiation therapy. 
• Diffuse liver metastasis is very rare and difficult to diagnose as they are not 
identifiable on routine radiographic diagnostic studies6. There are multiple case 
reports of occult metastatic breast cancer in the liver presenting with acute liver 
failure, in patients with a history of breast cancer3,4,7,8,9,10.
• In few reported cases, early diagnosis and treatment resulted in some improvement 
beyond the 18-24 months expected prognosis in metastatic breast cancer, but most 
cases were fatal within 2-9 months of diagnosis11.
HIDA Scan +
Diagnostic Paracentesis Bile Duct Injury Ruled out
Autoimmune, 
Hepatitis, EBV,
HIV, TB, AFP
work-up sent
Work-Up Negative; patient continued to decline 
with development of spontaneous bacterial 
peritonitis, abnormal PT/PTT and platelet count.
Laparoscopic Cholecystectomy 
for acute cholecystitis; liver 
appeared cirrhotic. 
Intraoperative biopsy taken.
Presentation at Henry Ford ED s/p 3 
weeks from laparoscopic 
cholecystectomy with total bilirubin = 
10.2: concern for intra-operative bile 
duct injury.
Outside hospital liver biopsy 
slides obtained and read as 
inconclusive. Repeat biopsy at 
HFHS demonstrated cirrhosis and 
advanced fibrosis of the liver. 
IHC staining revealed 
adenocarcionma, most 
consistent with primary breast 
carcinoma
Repeat Liver 
Biopsy
Reassess:
• Patient’s functional status
• Potential for systemic chemotherapy
• Goals of care  
Case discussed with 
hematology/oncology. Patient’s 
overall functional status and 
liver failure were incompatible 
with systemic chemotherapy. 
She was not a transplate 
candidate due to metastatic 
disease. Goals of care 
discussed with patient and 
family; hospice initiated.
Figure 1. Hospital Course Flow Chart
Figure 2. Pathology Slide 
demonstrating liver parenchyma 
infiltrated by tumor cells
Figure 6. CT Liver demonstrating diffuse changes 
without evidence of discrete mass
Figure 3. Tumors cells with eosinophilic 
cytoplasm and eccentrically placed 
hyperchromatic nuclei
Tumor cells are positive for CK7 and GATA 3 supporting 
breast primary.
Biopsy Pathology Slide Images courtesy of Beena U Ahsan, MD, 
Henry Ford Hospital Department of Pathology
Figure 4. CK7 staining. Figure 5. GATA 3 staining
